Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer

Journal of Clinical Microbiology

Volumn 48, Issue 10, 2010, Pages 3648-3653

  Borman, Andrew M ^a   Linton, Christopher J ^a   Oliver, Debra ^a   Palmer, Michael D ^a   Szekely, Adrien ^a   Johnson, Elizabeth M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERNAL TRANSCRIBED SPACER 2; NUCLEOTIDE; RIBOSOME RNA;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; FUNGAL VIRULENCE; FUNGUS IDENTIFICATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS;

DNA, FUNGAL; DNA, RIBOSOMAL SPACER; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; MYCOLOGY; MYCOSES; SEQUENCE ANALYSIS, DNA; TIME FACTORS; YEASTS;

EID: 77957808735     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01071-10     Document Type: Article

References (27)

1. Bhally, H. S., S. Jain, C. Shields, N. Halsey, E. Cristofalo, and W. G. Merz. 2006. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med. Mycol. 44:185-187.
2. Borman, A. M., M. Fraser, C. J. Linton, M. D. Palmer, and E. M. Johnson. 2010. An improved method for the preparation of total genomic DNA from isolates of yeast and mould using Whatman FTA filter papers. Mycopathologia 169:445-449.
3. Borman, A. M., C. J. Linton, D. Oliver, M. D. Palmer, A. Szekely, F. C. Odds, and E. M. Johnson. 2009. Pyrosequencing analysis of 20 nucleotides of the internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. J. Clin. Microbiol. 47:2307-2310.
4. Borman, A. M., R. Petch, C. J. Linton, M. D. Palmer, P. D. Bridge, and E. M. Johnson. 2008. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J. Clin. Microbiol. 46:933-938.
5. Boyanton, B. L., R. A. Luna, L. R. Fasciano, K. G. Menne, and J. Versalovic. 2008. DNA pyrosequencing-based identification of pathogenic Candida species by using the internal transcribed spacer 2 region. Arch. Pathol. Lab. Med. 132:667-674.
6. Campbell, C. K., K. G. Davey, A. D. Holmes, A. Szekely, A., and D. W. Warnock. 1999. Comparison of the API Candida system with the AUXACOLOR2 system for identification of common yeast pathogens. J. Clin. Microbiol. 37:821-823.
7. Chen, Y.-C., J. D. Eisner, M. M. Kattar, S. L. Rassoulian-Barrett, K. LaFe, U. Bui, A. P. Limaye., and B. T. Cookson. 2001. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J. Clin. Microbiol. 39:4042-4051.
8. Chen, Y.-C., J. D. Eisner, M. M. Kattar, S. L. Rassoulian-Barrett, K. LaFe, S. L. Yarfitz, A. P. Limaye, and B. T. Cookson. 2000. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer region 2 of the rRNA genes. J. Clin. Microbiol. 38:2302-2310.
9. Fromtling, R. A. 2007. Mycology. In P. R. Murray, E. J. Baron, J. Jorgensen, M. A. Pfaller, and M. L. Landry (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
10. Gharizadeh, B., E. Norberg, J. Loffler, S. Jalal, J. Tollemar, H. Einsele, L. Klingspor, and P. Nyren. 2004. Identification of medically important fungi by the Pyrosequencing technology. Mycoses 47:29-33.
11. Gomez-Lopez, A., A. Alatruey-Izquierdo, D. Rodriguez, B. Almirante, A. Pahissa, J. L. Rodriguez-Tudela, M. Cuenca-Estrella, and the Barcelona Candidemia Project Study Group. 2008. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob. Agents Chemother. 52:1506-1509.
12. Johnson, E. M., and D. W. Warnock. 1995. Azole drug resistance in yeasts. J. Antimicrob. Chemother. 36:751-755.
13. Law, D., C. B. Moore, H. M. Wardle, L. A. Ganguli, and D. W. Denning. 1994. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J. Antimicrob. Chemother. 34:659-668.
14. Leaw, S. N., H. C. Chang, H. F. Sun, R. Barton, J.-P. Bouchara, and T. C. Chang. 2006. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J. Clin. Microbiol. 44: 693-699.
15. Linton, C. J., A. M. Borman, G. Cheung, A. D. Holmes, A. Szekeley, M. D. Palmer, P. D. Bridge, C. K. Campbell, and E. M. Johnson. 2007. Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years experience at the United Kingdom Mycology Reference Laboratory. J. Clin. Microbiol. 45:1152-1158.
16. Marr, K. A. 2004. Invasive Candida infections: the changing epidemiology. Oncology 14:9-14.
17. Montero, C. I., Y. R. Shea, P. A. Jones, S. M. Harrington, N. E. Tooke, F. G. Witebsky, and P. R. Murray. 2008. Evaluation of Pyrosequencing® technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur. J. Clin. Microbiol. Infect. Dis. 27:821-830.
18. Nucci, M., and K. A. Marr. 2005. Emerging fungal diseases. Clin. Infect. Dis. 41:521-526.
19. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
20. Pfaller, M. A., R. N. Jones, G. V. Doern, A. C. Fluit, J. Verhoef, H. S. Sadler, S. A. Messer, A. Houston, S. Coffman, and R. J. Hollis. 1999. International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn. Microbiol. Infect. Dis. 35:19-25.
21. Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wenzel. 1998. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 31:327-332.
22. Ruhnke, M. 2006. Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr. Drug Targets 7:495-504.
23. Snydman, D. R. 2003. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 123:500S-503S.
24. Tavanti, A., A. D. Davidson, N. A. R Gow, M. C. J. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
25. Wingard, J. R. 1994. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin. Infect. Dis. 19(Suppl. 1):49-53.
26. Wright, W. L., and R. P. Wenzel. 1997. Nosocomial Candida. Epidemiology, transmission and prevention. Infect. Dis. Clin. North Am. 11:411-425.
27. Yang, R., D. Li, and J. Zhao. 2001. 26SrDNA D1/D2 domain sequence analysis of the pathogenic strain of the first case of disseminated trichosporonosis in China. Zhonghua Yi Xue Za Zhi 81:472-475.